2022
DOI: 10.3390/pharmaceutics14122597
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of Bacterial Extracellular Membrane Nanovesicles in Infectious Diseases and Their Application in Medicine

Abstract: Bacterial extracellular membrane nanovesicles (EMNs) are attracting the attention of scientists more and more every year. These formations are involved in the pathogenesis of numerous diseases, among which, of course, the leading role is occupied by infectious diseases, the causative agents of which are a range of Gram-positive and Gram-negative bacteria. A separate field for the study of the role of EMN is cancer. Extracellular membrane nanovesicles nowadays have a practical application as vaccine carriers fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 202 publications
0
1
0
Order By: Relevance
“…215 Bacterial extracellular vesicles (BEVs), which are promising natural nanocarriers, 216 have shown great potential in various treatments, including drug delivery, 217 tumor immunotherapy, 218 and the treatment of infectious diseases. 219 Particularly, preparing BEV-based nanovaccines has become a research hotspot in recent years. 220,221 For example, Li et al 222 proposed an in situ vaccine based on OMVs from E. coli BL21-CodonPlus (DE3) to promote immune-mediated tumor clearance after photothermal therapy by orchestrating antigen capture and immune regulation.…”
Section: Bacterial Membrane-camouflaged Ndds (Bm-ndds)mentioning
confidence: 99%
“…215 Bacterial extracellular vesicles (BEVs), which are promising natural nanocarriers, 216 have shown great potential in various treatments, including drug delivery, 217 tumor immunotherapy, 218 and the treatment of infectious diseases. 219 Particularly, preparing BEV-based nanovaccines has become a research hotspot in recent years. 220,221 For example, Li et al 222 proposed an in situ vaccine based on OMVs from E. coli BL21-CodonPlus (DE3) to promote immune-mediated tumor clearance after photothermal therapy by orchestrating antigen capture and immune regulation.…”
Section: Bacterial Membrane-camouflaged Ndds (Bm-ndds)mentioning
confidence: 99%